BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10763409)

  • 1. Celecoxib (Celebrex): 1 year later.
    McMorran M; Morawiecka I
    CMAJ; 2000 Apr; 162(7):1044-6, 1048-50. PubMed ID: 10763409
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis.
    Goldstein JL; Correa P; Zhao WW; Burr AM; Hubbard RC; Verburg KM; Geis GS
    Am J Gastroenterol; 2001 Apr; 96(4):1019-27. PubMed ID: 11316141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assessment of the gastrointestinal and cardiovascular risk-benefit of celecoxib compared to individual NSAIDs at the population level.
    Varas-Lorenzo C; Maguire A; Castellsague J; Perez-Gutthann S
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):366-76. PubMed ID: 16897817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Celecoxib induced toxiderma with positive patch-test].
    Verbeiren S; Morant C; Charlanne H; Ajebbar K; Caron J; Modiano P
    Ann Dermatol Venereol; 2002 Feb; 129(2):203-5. PubMed ID: 11937958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gastroduodenal tolerance of celecoxib (celebrex) in patients with osteoarthrosis: an endoscopic evaluation].
    Karateev AE
    Ter Arkh; 2001; 73(5):63-4. PubMed ID: 11517755
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hyperkalemia and celecoxib].
    Rego MJ; Fonseré N; Martí S; Rey-Joly C
    Med Clin (Barc); 2002 Jun; 119(1):36-7. PubMed ID: 12062005
    [No Abstract]   [Full Text] [Related]  

  • 7. Anaphylaxis to celecoxib.
    Levy MB; Fink JN
    Ann Allergy Asthma Immunol; 2001 Jul; 87(1):72-3. PubMed ID: 11476468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anaphylactic shock induced by celecoxib].
    Habki R; Vermeulen C; Bachmeyer C; Charoud A; Mofredj A
    Ann Med Interne (Paris); 2001 Sep; 152(5):355. PubMed ID: 11593149
    [No Abstract]   [Full Text] [Related]  

  • 9. Toxic epidermal necrolysis due to administration of celecoxib (Celebrex).
    Friedman B; Orlet HK; Still JM; Law E
    South Med J; 2002 Oct; 95(10):1213-4. PubMed ID: 12425513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of celecoxib in patients with adverse reactions to nimesulide.
    Liccardi G; D'Amato G; Canonica GW; Lobefalo G; Noschese P; Piccolo A; Salzillo A; Passalacqua G
    Allergy; 2005 May; 60(5):708-9. PubMed ID: 15813826
    [No Abstract]   [Full Text] [Related]  

  • 11. [Celebrex: confirmed effectiveness and safety (new data)].
    Nasonov EL
    Ter Arkh; 2001; 73(5):57-61. PubMed ID: 11517753
    [No Abstract]   [Full Text] [Related]  

  • 12. Are rofecoxib and celecoxib safer NSAIDS?
    Drug Ther Bull; 2000 Nov; 38(11):81-6. PubMed ID: 11138599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celecoxib-induced upper gastrointestinal hemorrhage and ulceration.
    Crawford AS; White JG
    South Med J; 2002 Dec; 95(12):1444-6. PubMed ID: 12597315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celecoxib-induced photoallergic drug eruption.
    Yazici AC; Baz K; Ikizoglu G; Kokturk A; Uzumlu H; Tataroglu C
    Int J Dermatol; 2004 Jun; 43(6):459-61. PubMed ID: 15186233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COX-2 inhibitors and Celebrex: safe or suspect?
    Health News; 1999 Jun; 5(7):4. PubMed ID: 10932776
    [No Abstract]   [Full Text] [Related]  

  • 16. The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis.
    Maetzel A; Krahn M; Naglie G
    Arthritis Rheum; 2003 Jun; 49(3):283-92. PubMed ID: 12794781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor.
    Goldstein JL; Silverstein FE; Agrawal NM; Hubbard RC; Kaiser J; Maurath CJ; Verburg KM; Geis GS
    Am J Gastroenterol; 2000 Jul; 95(7):1681-90. PubMed ID: 10925968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adverse cutaneous reaction to celecoxib: 6 cases].
    Murr D; Bocquet H; Lelouet H; Fischer RM; Revuz J; Cosnes A
    Ann Dermatol Venereol; 2003 May; 130(5):519-21. PubMed ID: 12843828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Labeling changes for arthritis drug.
    FDA Consum; 2002; 36(5):6. PubMed ID: 12412538
    [No Abstract]   [Full Text] [Related]  

  • 20. Exacerbation of inflammatory bowel disease associated with use of celecoxib.
    Bonner GF
    Am J Gastroenterol; 2001 Apr; 96(4):1306-8. PubMed ID: 11316199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.